IT1238011B - Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna.
- Google Patents
Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna.
Info
Publication number
IT1238011B
IT1238011BIT04865889AIT4865889AIT1238011BIT 1238011 BIT1238011 BIT 1238011BIT 04865889 AIT04865889 AIT 04865889AIT 4865889 AIT4865889 AIT 4865889AIT 1238011 BIT1238011 BIT 1238011B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pulitzer ItalianafiledCriticalPulitzer Italiana
Priority to IT04865889ApriorityCriticalpatent/IT1238011B/it
Publication of IT8948658A0publicationCriticalpatent/IT8948658A0/it
Publication of IT8948658A1publicationCriticalpatent/IT8948658A1/it
Application grantedgrantedCritical
Publication of IT1238011BpublicationCriticalpatent/IT1238011B/it
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
IT04865889A1989-12-131989-12-13Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna.
IT1238011B
(it)
Hydroxy Pipecolate Hydroxamic Acid Derivatives as MMP Inhibitors, Pharmaceutical Compositions Containing Them and Their Use for Treatment of Diseases caused by MMP
Neue delta-17 und delta-20 ungesätigte und gesatigte 17--g(b)-substituierte-4-aza-5-g(a)- androstan-3-on verbindungen als inhibitoren von 5-alpha-reductase